Bruck Kifle

Array ( [id] => 6257734 [patent_doc_number] => 20100029705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'BETA-2-ADRENORECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/577855 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18871 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029705.pdf [firstpage_image] =>[orig_patent_app_number] => 12577855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132956 [patent_doc_number] => 07696206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => '2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/569720 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31662 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696206.pdf [firstpage_image] =>[orig_patent_app_number] => 12569720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644596 [patent_doc_number] => 08022202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Dihydrodiazepines useful as inhibitors of protein kinases' [patent_app_type] => utility [patent_app_number] => 12/569237 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53552 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022202.pdf [firstpage_image] =>[orig_patent_app_number] => 12569237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6222790 [patent_doc_number] => 20100056501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/564331 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35129 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056501.pdf [firstpage_image] =>[orig_patent_app_number] => 12564331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549875 [patent_doc_number] => 20100016578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'MACROCYCLIC SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/563072 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75995 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016578.pdf [firstpage_image] =>[orig_patent_app_number] => 12563072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846328 [patent_doc_number] => 08455510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/119700 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 14079 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6595007 [patent_doc_number] => 20100048541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/561420 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35081 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048541.pdf [firstpage_image] =>[orig_patent_app_number] => 12561420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494740 [patent_doc_number] => 20100009966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'SUBSTITUTED LACTAMS AS INHIBITORS OF ABETA PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/560213 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35085 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009966.pdf [firstpage_image] =>[orig_patent_app_number] => 12560213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555527 [patent_doc_number] => 08067428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Platelet ADP receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 12/559389 [patent_app_country] => US [patent_app_date] => 2009-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22652 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067428.pdf [firstpage_image] =>[orig_patent_app_number] => 12559389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676962 [patent_doc_number] => 08815872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Macrocyclics pyrimidines as aurora kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/062413 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30534 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239396 [patent_doc_number] => 08604188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Washing of an organic phase comprising caprolactam' [patent_app_type] => utility [patent_app_number] => 13/060885 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5680 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494709 [patent_doc_number] => 20100009965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'CYCLIC MALONAMIDES AS INHIBITORS OF ABETA PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/552652 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42731 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009965.pdf [firstpage_image] =>[orig_patent_app_number] => 12552652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189913 [patent_doc_number] => 20110172205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'MONOCYCLIC AMIDE CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/062540 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15881 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172205.pdf [firstpage_image] =>[orig_patent_app_number] => 13062540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590573 [patent_doc_number] => 20100130479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Gabaergic Agents to Treat Memory Deficits' [patent_app_type] => utility [patent_app_number] => 12/551149 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 24715 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130479.pdf [firstpage_image] =>[orig_patent_app_number] => 12551149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4533910 [patent_doc_number] => 07872001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Gamma d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/583917 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1417 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872001.pdf [firstpage_image] =>[orig_patent_app_number] => 12583917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460906 [patent_doc_number] => 07879841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Delta D-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/583914 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1425 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879841.pdf [firstpage_image] =>[orig_patent_app_number] => 12583914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398354 [patent_doc_number] => 20090318417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Gamma-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/583885 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1499 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318417.pdf [firstpage_image] =>[orig_patent_app_number] => 12583885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398356 [patent_doc_number] => 20090318419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/583915 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1409 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318419.pdf [firstpage_image] =>[orig_patent_app_number] => 12583915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398353 [patent_doc_number] => 20090318416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/583857 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1374 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318416.pdf [firstpage_image] =>[orig_patent_app_number] => 12583857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4613630 [patent_doc_number] => 07989617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Crown ether derivatives' [patent_app_type] => utility [patent_app_number] => 12/546179 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 31128 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989617.pdf [firstpage_image] =>[orig_patent_app_number] => 12546179 [rel_patent_id] =>[rel_patent_doc_number] =>)